Ocugen's Dry Eye Treatment Hit Its Primary Endpoint By Sam | March 19, 2018 Ocugen announced this morning that its mid-stage combination treatment hit its primary endpoint of tolerability in a proof-of-concept trial. Source: BioSpace Posted in BioPharma